ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: 20-F filed 2023-07-27

Name: ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED: 20-F filed 2023-07-27
Creator: ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED

What ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED reported in its annual report (foreign private issuer) filed 2023-07-27 (fiscal FY 2023): 47 published measures, 96 facts as tagged in accession 0001553350-23-000405.

This filing

Form: 20-F (annual report (foreign private issuer))
Filed: 2023-07-27
Fiscal period: fiscal FY 2023
Accession: 0001553350-23-000405 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2023-03-31	2,280,444	USD
At 2022-03-31	2,852,875	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2023-03-31	2,610,389	USD
At 2022-03-31	1,911,475	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2023-03-31	-346,570	USD
At 2022-03-31	941,400	USD
At 2021-03-31	1,500,493	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-2,285,857	USD	365
2021-04-01 to 2022-03-31	-1,125,565	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-999,155	USD	365
2021-04-01 to 2022-03-31	-396,969	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	22,369	USD	365
2021-04-01 to 2022-03-31	0	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	1,662,600	USD	365
2021-04-01 to 2022-03-31	2,328,526	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	1,295,763	USD	365
2021-04-01 to 2022-03-31	263,042	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	118,131	USD	365
2021-04-01 to 2022-03-31	0	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2023-03-31	-3,164,249	USD
At 2022-03-31	-1,367,834	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	17,666,043	shares	365
2021-04-01 to 2022-03-31	17,283,258	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	17,666,043	shares	365
2021-04-01 to 2022-03-31	17,283,258	shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-8,840	USD	365
2021-04-01 to 2022-03-31	11,119	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2023-03-31	4,772	USD
At 2022-03-31	7,007	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	54,506	USD	365
2021-04-01 to 2022-03-31	318,137	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-1,253,496	USD	365
2021-04-01 to 2022-03-31	-685,759	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2023-03-31	1,200,263	USD
At 2022-03-31	2,082,902	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	46,723	USD	365
2021-04-01 to 2022-03-31	35,241	USD	365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2023-03-31	2,014,802	USD
At 2022-03-31	835,574	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2023-03-31	353,703	USD
At 2022-03-31	194,138	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	2,771,413	USD	365
2021-04-01 to 2022-03-31	2,594,012	USD	365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2023-03-31	131,474	USD
At 2022-03-31	57,283	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	1,517,917	USD	365
2021-04-01 to 2022-03-31	1,908,253	USD	365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	144,683	USD	365
2021-04-01 to 2022-03-31	420,273	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	357,823	USD	365
2021-04-01 to 2022-03-31	680,313	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2023-03-31	17,679,618	shares
At 2022-03-31	17,547,118	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2023-03-31	277,836	USD
At 2022-03-31	101,719	USD
At 2021-03-31	194,590	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2023-03-31	2,703,081	USD
At 2022-03-31	2,115,207	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2023-03-31	96,918	USD
At 2022-03-31	176,480	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2023-03-31	-329,945	USD
At 2022-03-31	941,400	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2023-03-31	513,409	USD
At 2022-03-31	723,604	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2023-03-31	675,647	USD
At 2022-03-31	836,086	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2023-03-31	22,369	USD
At 2022-03-31	42,471	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2023-03-31	17,597	USD
At 2022-03-31	35,464	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2023-03-31	448,093	USD
At 2022-03-31	161,709	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2023-03-31	280,424	USD
At 2022-03-31	196,434	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-2,230,988	USD	365
2021-04-01 to 2022-03-31	-1,125,565	USD	365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-2,365,419	USD	365
2021-04-01 to 2022-03-31	-1,139,900	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-2,230,988	USD	365
2021-04-01 to 2022-03-31	-1,125,565	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	753,693	USD	365
2021-04-01 to 2022-03-31	1,025,725	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	4,596	USD	365
2021-04-01 to 2022-03-31	4,694	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-505,721	USD	365
2021-04-01 to 2022-03-31	14,215	USD	365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	-8,840	USD	365
2021-04-01 to 2022-03-31	11,119	USD	365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	0	USD	365
2021-04-01 to 2022-03-31	0	USD	365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	46,723	USD	365
2021-04-01 to 2022-03-31	35,361	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	277,223	USD	365
2021-04-01 to 2022-03-31	70,611	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-04-01 to 2023-03-31	110,699	USD	365
2021-04-01 to 2022-03-31	182,531	USD	365

Inspect the source

Entity: ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED / CIK 0001672886
Captured: 2026-09-21T17:22:51.018Z
SEC response SHA-256: 5779345d654e0c5bdccd0db49d6a4f5f72a8525c49074d7feb9e4523f0bd33c1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001672886.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))